TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32419473

Group type: EXPERIMENTAL
Intervention: Lenvatinib treatment for patients weighing <60 kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenvatinib treatment for patients weighing ≥60 kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib treatment
Number of subjects: 0
Study: 35833069

Group type: EXPERIMENTAL
Intervention: Individualized pelvic floor muscle training (PFMT) with transperineal ultrasound (TPUS) biofeedback
Number of subjects: 77

Group type: COMPARATOR
Intervention: Individualized pelvic floor muscle training (PFMT) without TPUS biofeedback (control group)
Number of subjects: 77
Study: 32586349

Group type: EXPERIMENTAL
Intervention: Core outcome sets (COS) for research and routine care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inclusion of COS in electronic health records (EHR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient‐centred outcomes
Number of subjects: 0
Study: 35212278

Group type: EXPERIMENTAL
Intervention: Zuo acupuncture treatment plus lifestyle interventions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group receiving prediabetes health education for lifestyle interventions
Number of subjects: 60
Study: 35432836

Group type: EXPERIMENTAL
Intervention: Intensive psychological nursing intervention
Number of subjects: 134

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 134
Study: 33486596

Group type: EXPERIMENTAL
Intervention: Reduced 2016‐AAO dose (2–3 mg/kg/day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Full 2016‐AAO dose (5 mg/kg/day)
Number of subjects: 73
Study: 35440667

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus bevacizumab (TT‐B)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Capecitabine plus bevacizumab (C‐B)
Number of subjects: 153
Study: 33653121

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg over 40 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg over 40 minutes)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 17
Study: 35450945

Group type: EXPERIMENTAL
Intervention: Kaia COPD app
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34060462

Group type: EXPERIMENTAL
Intervention: Three-day post-operative course of oral antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three-day post-operative course of intravenous antibiotics
Number of subjects: 0
Study: 34931477

Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 35841082

Group type: EXPERIMENTAL
Intervention: Men in Mind training (self-paced online training program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 32629091

Group type: EXPERIMENTAL
Intervention: Bag-mask ventilation (BMV)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Endotracheal intubation (ETI)
Number of subjects: 409
Study: 35063943

Group type: EXPERIMENTAL
Intervention: Bevacizumab in combination with frontline carboplatin and paclitaxel chemotherapy
Number of subjects: 0
Study: 32338110

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 50
Study: 33478885

Group type: EXPERIMENTAL
Intervention: Hamstring Outcome Score (HaOS)
Number of subjects: 400
Study: 34160673

Group type: EXPERIMENTAL
Intervention: Headless compression screw (HCS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tension band wire (TBW)
Number of subjects: 60
Study: 34510176

Group type: EXPERIMENTAL
Intervention: Protein ingestion (40g) during hemodialysis (PRO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein ingestion with exercise (PRO+EX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo ingestion during hemodialysis (PLA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo ingestion with exercise (PLA+EX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein ingestion (PRO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo ingestion (PLA)
Number of subjects: 10
Study: 35183671

Group type: EXPERIMENTAL
Intervention: True air filtration
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham air filtration
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PM2.5 exposure increase
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PM2.5 exposure
Number of subjects: 54
Study: 34143258

Group type: EXPERIMENTAL
Intervention: LV‐RBP (52.5 g of PMF104 in 500 mL of water)
Number of subjects: 110

Group type: COMPARATOR
Intervention: FV‐RBP (105 g of PMF104 in 1000 mL of water)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: LV‐RBP
Number of subjects: 110

Group type: COMPARATOR
Intervention: FV‐RBP
Number of subjects: 110
Study: 32423422

Group type: EXPERIMENTAL
Intervention: Local solutions implemented to strengthen LTBI management
Number of subjects: 125
Study: 35503773

Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC)
Number of subjects: 20
Study: 34689837

Group type: EXPERIMENTAL
Intervention: RGw-mHealth (LLRP + IDC + mHealth)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: RGwo-mHealth (LLRP + IDC)
Number of subjects: 114

Group type: COMPARATOR
Intervention: CG (IDC)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: RGw-mHealth
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: RGwo-mHealth
Number of subjects: 114

Group type: COMPARATOR
Intervention: CG
Number of subjects: 114
Study: 35755843

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 648
Study: 33593307

Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) specialist consultation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Rheumatologist consultation
Number of subjects: 400
Study: 33782959

Group type: EXPERIMENTAL
Intervention: TA (4 mg/mL) intradermal injections every 2 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TA (10 mg/mL) intradermal injections every 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical TA cream (10% concentration) twice daily
Number of subjects: 60
Study: 33051867

Group type: EXPERIMENTAL
Intervention: START‐Play intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: usual early intervention (uEI) services
Number of subjects: 103
Study: 36113023

Group type: EXPERIMENTAL
Intervention: High-fiber, high-fruit and vegetable, and low-fat dietary intervention
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Pretrial dietary fiber intake
Number of subjects: 368
Study: 34292305

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 261

Group type: COMPARATOR
Intervention: No Carboplatin (Control)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Carboplatin in group 3 subgroup
Number of subjects: 261

Group type: COMPARATOR
Intervention: No Carboplatin in group 3 subgroup (Control)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Overall survival by molecular subgroup
Number of subjects: 261
Study: 33806904

Group type: EXPERIMENTAL
Intervention: Green synthesized ZnO-NPs (GS1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Commercially available ZnO-NPs (C1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Commercially available ZnO-NPs (C2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (0% ZnO-NPs)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Green synthesized ZnO-NPs (GS2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All experimental groups (exposed to ZnO-NPs)
Number of subjects: 150
Study: 32433914

Group type: EXPERIMENTAL
Intervention: Fork-tip needles (22-gauge and 25-gauge)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Fork-tip needles
Number of subjects: 192

Group type: COMPARATOR
Intervention: Side-fenestrated needles
Number of subjects: 192
Study: 34045151

Group type: EXPERIMENTAL
Intervention: AI‐enabled automatic segmentation
Number of subjects: 3
Study: 32176175

Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy and observation
Number of subjects: 20
Study: 34859313

Group type: EXPERIMENTAL
Intervention: Dry suction technique
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Wet suction technique
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Slow pull technique
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 22G FNB needle design 1
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 22G FNB needle design 2
Number of subjects: 51

Group type: COMPARATOR
Intervention: Overall results
Number of subjects: 51
Study: 32998523

Group type: COMPARATOR
Intervention: Conventional transhiatal esophagectomy
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy using a mediastinoscope
Number of subjects: 62
Study: 33500282

Group type: EXPERIMENTAL
Intervention: Deprexis (online intervention) in addition to care as usual (CAU)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 1013
Study: 33406543

Group type: EXPERIMENTAL
Intervention: NICaS group (n=68)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Picco group (n=67)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Experience group (n=65)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NICaS group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Picco group
Number of subjects: 200
Study: 35410308

Group type: EXPERIMENTAL
Intervention: Whole-school social-marketing intervention to promote sexual health
Number of subjects: 6440
Study: 32735114

Group type: EXPERIMENTAL
Intervention: Multidirectional walking (WALK)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care (CONT)
Number of subjects: 35
Study: 34936978

Group type: EXPERIMENTAL
Intervention: Choropleth map
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Graduated-circle map
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thematic maps (Choropleth and Graduated-circle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tabular data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Past occurrence information (2016 ZIKV outbreaks)
Number of subjects: 0
Study: 33320856

Group type: EXPERIMENTAL
Intervention: Multiplex RT-qPCR assay for SARS-CoV-2 detection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial assays
Number of subjects: 0
Study: 32790904

Group type: EXPERIMENTAL
Intervention: Vortioxetine (15 mg/daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Paroxetine (20 mg/daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sertraline (50 mg/daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Escitalopram (10 mg/daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Duloxetine (60 mg/daily)
Number of subjects: 150
Study: 35087644

Group type: EXPERIMENTAL
Intervention: Vignettes describing killing an innocent civilian
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vignettes describing killing a person carrying a bomb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Descriptions of police officers enforcing COVID-19 restrictions
Number of subjects: 0
Study: 32228545

Group type: EXPERIMENTAL
Intervention: Non-health goal (looking better)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Health goal (increasing life expectancy)
Number of subjects: 407
Study: 34881520

Group type: EXPERIMENTAL
Intervention: VIPP‐SD
Number of subjects: 66

Group type: COMPARATOR
Intervention: Dummy intervention
Number of subjects: 66
Study: 34006069

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with titanium‐reinforced polytetrafluoroethylene membrane and simultaneous implant placement (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with titanium mesh and collagen membrane and simultaneous implant placement (Group B)
Number of subjects: 40
Study: 32027683

Group type: EXPERIMENTAL
Intervention: Randomization test in multiple baseline design
Number of subjects: 0
Study: 34534293

Group type: EXPERIMENTAL
Intervention: Maternal vitamin D sufficiency (25(OH)D ≥ 30 ng/ml) in the third trimester
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Maternal 25(OH)D sufficiency category
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Maternal vitamin D sufficiency among males
Number of subjects: 680
Study: 34958861

Group type: EXPERIMENTAL
Intervention: 6'-Sialyllactose (6'-SL), 3 g powder orally administered twice a day for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (maltodextrin), 3 g powder orally administered twice a day for 12 weeks
Number of subjects: 0
Study: 33755835

Group type: EXPERIMENTAL
Intervention: Serum CYR61 ≥ 236.2 pg/mL
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Serum CYR61
Number of subjects: 72
Study: 34593076

Group type: EXPERIMENTAL
Intervention: Healthy Caregivers-Healthy Children (HC2) intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control CCC
Number of subjects: 24
Study: 33227631

Group type: EXPERIMENTAL
Intervention: NMOSD patients (with history of optic neuritis)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: NMOSD patients (without history of optic neuritis)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: RRMS patients (with and without history of optic neuritis)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 98
Study: 33380333

Group type: EXPERIMENTAL
Intervention: Daubechies-3 wavelet with 7 levels of WT
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Symlets-3 wavelet with 7 levels of WT
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Wavelet transforms in general
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sinusoidal waves
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Step functions
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Spike functions
Number of subjects: 105
Study: 35348021

Group type: EXPERIMENTAL
Intervention: diazepam (10 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 34597375

Group type: EXPERIMENTAL
Intervention: Consolidation radiotherapy (RT)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 116
Study: 32627641

Group type: EXPERIMENTAL
Intervention: Genetically predicted MAP at age ≤55 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetically predicted MAP at age >55 years
Number of subjects: 0
Study: 33713473

Group type: EXPERIMENTAL
Intervention: Trapezius muscle injection (TMI) with 5 mL of 0.25% bupivacaine two times, with a 1-week interval
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of 0.125% bupivacaine in the second week after TMI
Number of subjects: 60

Group type: COMPARATOR
Intervention: Repeated TMI (two injections)
Number of subjects: 60
Study: 33451343

Group type: EXPERIMENTAL
Intervention: Miniscrew anchorage
Number of subjects: 22

Group type: COMPARATOR
Intervention: Trans palatal arch (TPA) anchorage
Number of subjects: 22
Study: 35428952

Group type: EXPERIMENTAL
Intervention: Single bout of eccentric exercise 1 week prior to tissue sampling
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Single bout of eccentric exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 30
Study: 32205201

Group type: COMPARATOR
Intervention: Control (PA0) - adhesive ExciTE F applied as per the manufacturer's recommendations
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PA2 - 2 wt% proanthocyanidins solution applied for 60s
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PA5 - 5 wt% proanthocyanidins solution applied for 60s
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups (PA0, PA2, PA5)
Number of subjects: 45
Study: 34648685

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg PO daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Finasteride (2.5 mg PO daily) in combination with topical clindamycin 2% solution
Number of subjects: 65
Study: 32278330

Group type: EXPERIMENTAL
Intervention: Conventional open-ended needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: Double side-vented needle
Number of subjects: 100
Study: 33016187

Group type: EXPERIMENTAL
Intervention: Virtual care (VC) including digital symptoms collection and telemedicine in addition to usual in-person physician consultation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Virtual care (VC)
Number of subjects: 28
Study: 34010679

Group type: EXPERIMENTAL
Intervention: Limited Restrictions group (normal activities other than pelvic rest)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Restrictions group (traditional postoperative restrictions for 6 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Limited Restrictions group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Restrictions group
Number of subjects: 36
Study: 32788673

Group type: EXPERIMENTAL
Intervention: Responsive feeding promotion from birth to 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36013498

Group type: EXPERIMENTAL
Intervention: Topical instillation of 0.3% ofloxacin, 4 drops at 15 min intervals before surgery
Number of subjects: 91
Study: 32125197

Group type: EXPERIMENTAL
Intervention: Bibloc appliance
Number of subjects: 302

Group type: COMPARATOR
Intervention: Monobloc appliance
Number of subjects: 302
Study: 35178811

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg once a day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32183336

Group type: EXPERIMENTAL
Intervention: Libraries 2% and 3% variants
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Libraries 5 and 6 variants
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Variant P5F3 (F41L‐ΔW42‐ΔD43‐K44P) from library 3
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Variant P5F3
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Wildtype BSLA
Number of subjects: 3000
Study: 35501628

Group type: EXPERIMENTAL
Intervention: Mandated case review for high-risk opioid patients
Number of subjects: 44042

Group type: COMPARATOR
Intervention: Non-mandated case review for high-risk opioid patients
Number of subjects: 44042
Study: 32375754

Group type: EXPERIMENTAL
Intervention: iCBT (internet-based cognitive-behavioral therapy) intervention for PTSD, 5 weeks duration, 10 writing assignments (twice a week)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: iCBT (internet-based cognitive-behavioral therapy) intervention for PTSD
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 37
Study: 36422503

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (Group B)
Number of subjects: 80
Study: 35061635

Group type: EXPERIMENTAL
Intervention: Closed-loop vasopressor (CLV) system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (manual adjustment by ICU nurse)
Number of subjects: 40
Study: 33677626

Group type: EXPERIMENTAL
Intervention: Cooked meals (gelatinised starch)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Finely milled whole-wheat
Number of subjects: 18

Group type: COMPARATOR
Intervention: Uncooked meals (native starch)
Number of subjects: 18
Study: 32202366

Group type: EXPERIMENTAL
Intervention: RMT
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: SWAT-T
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Effective applications
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Partially effective applications
Number of subjects: 176
Study: 35018508

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 33972368

Group type: EXPERIMENTAL
Intervention: Genetically predicted CRP concentration
Number of subjects: 16918

Group type: EXPERIMENTAL
Intervention: Subgroup analyses by stage at diagnosis or tumor location
Number of subjects: 16918
Study: 32847391

Group type: EXPERIMENTAL
Intervention: Genetically determined FVIII
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically determined VWF
Number of subjects: 0

Group type: COMPARATOR
Intervention: FVII, FXI, fibrinogen
Number of subjects: 0
Study: 34914339

Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy
Number of subjects: 5018

Group type: COMPARATOR
Intervention: Endocrine-only therapy
Number of subjects: 5018
Study: 35241133

Group type: EXPERIMENTAL
Intervention: Specific strengthening of the first dorsal interosseous muscle
Number of subjects: 56

Group type: COMPARATOR
Intervention: Traditional protocol (control)
Number of subjects: 56
Study: 35126921

Group type: EXPERIMENTAL
Intervention: Preoperative rehabilitation training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine clinical nursing
Number of subjects: 120
Study: 34555043

Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia with dexmedetomidine, sevoflurane, and thoracic paravertebral blockade
Number of subjects: 97

Group type: COMPARATOR
Intervention: Opioid-based anesthesia with remifentanil, sevoflurane, and thoracic paravertebral blockade
Number of subjects: 97
Study: 35753340

Group type: COMPARATOR
Intervention: No intervention group
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Skin intervention group
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Food intervention group
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Combined intervention group
Number of subjects: 2397
Study: 34526318

Group type: EXPERIMENTAL
Intervention: Early percutaneous mitral commissurotomy (PMC)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 167
Study: 35191972

Group type: EXPERIMENTAL
Intervention: AI audiovisual metric-based feedback (VOA group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Synchronous verbal scripted debriefing and instruction from a remote expert (instructor group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 70
Study: 33828043

Group type: EXPERIMENTAL
Intervention: Eye examination for low vision rehabilitation
Number of subjects: 201
Study: 34139405

Group type: EXPERIMENTAL
Intervention: Music MIP
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Memory MIP
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Music+Memory MIP
Number of subjects: 401

Group type: COMPARATOR
Intervention: Neutral MIPs
Number of subjects: 401